Floatz logo

Inno-206

Granulocyte Colony-Stimulating Factor

Second Affiliated Hospital of Soochow UniversityPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Granulocyte Colony-Stimulating Factor cohort.

Asset / SponsorPhaseRating
Rhgm-Csf
Ruijin Hospital
Phase 4BB
Peg-Rhg-Csf
Ruijin Hospital
Phase 4BB
FILGRASTIM
Nanfang Hospital, Southern Medical University
Phase 2/3B
Bortezomib
Second Affiliated Hospital of Soochow University
Phase 2CCC
PREDNISONE TABLETS
Second Affiliated Hospital of Soochow University
Phase 2CCC
Cyclophosphamide
Second Affiliated Hospital of Soochow University
Phase 2CCC
DEXAMETHASONE
Second Affiliated Hospital of Soochow University
Phase 2CCC

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
Recurrent Adult Acute Lymphoblastic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →